Dashboard
1
Strong Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 17.33%
- Healthy long term growth as Net Sales has grown by an annual rate of 11.09% and Operating profit at 25.92%
- Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 96.69
2
Positive results in Jun 25
3
With ROCE of 24.55%, it has a very attractive valuation with a 2.82 Enterprise value to Capital Employed
4
Consistent Returns over the last 3 years
Stock DNA
Industrial Manufacturing
JPY 539,163 Million (Mid Cap)
15.00
NA
0.00%
0.06
21.06%
4.52
Revenue and Profits:
Net Sales:
38,110 Million
(Quarterly Results - Jun 2025)
Net Profit:
3,642 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
9.06%
0%
9.06%
6 Months
68.85%
0%
68.85%
1 Year
57.69%
0%
57.69%
2 Years
145.69%
0%
145.69%
3 Years
348.39%
0%
348.39%
4 Years
73.32%
0%
73.32%
5 Years
116.5%
0%
116.5%
Organo Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
11.09%
EBIT Growth (5y)
25.92%
EBIT to Interest (avg)
96.69
Debt to EBITDA (avg)
0.46
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
1.12
Tax Ratio
25.25%
Dividend Payout Ratio
30.45%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
17.33%
ROE (avg)
14.66%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
2.91
EV to EBIT
11.48
EV to EBITDA
10.81
EV to Capital Employed
2.82
EV to Sales
2.19
PEG Ratio
0.37
Dividend Yield
0.01%
ROCE (Latest)
24.55%
ROE (Latest)
20.00%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
38,110.00
31,619.00
20.53%
Operating Profit (PBDIT) excl Other Income
7,405.00
4,428.00
67.23%
Interest
65.00
65.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
3,642.00
2,683.00
35.74%
Operating Profit Margin (Excl OI)
182.50%
126.60%
5.59%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 20.53% vs 6.78% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 35.74% vs 67.69% in Jun 2024
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
163,269.00
150,356.00
8.59%
Operating Profit (PBDIT) excl Other Income
33,046.00
24,555.00
34.58%
Interest
246.00
240.00
2.50%
Exceptional Items
0.00
0.00
Consolidate Net Profit
24,186.00
17,334.00
39.53%
Operating Profit Margin (Excl OI)
190.60%
149.90%
4.07%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 8.59% vs 13.54% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is 39.53% vs 47.35% in Mar 2024
About Organo Corp. 
Organo Corp.
Industrial Manufacturing
No Details Available.
Company Coordinates 
No Company Details Available






